| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025363 |
| Receipt No. | R000029196 |
| Official scientific title of the study | Pre-operative or post-operative misoprostol in ceasrean delivery:Dose it differ? |
| Date of disclosure of the study information | 2017/01/01 |
| Last modified on | 2016/12/21 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Pre-operative or post-operative misoprostol in ceasrean delivery:Dose it differ? | |
| Title of the study (Brief title) | Pre-operative or post-operative misoprostol in cesarean delivery: Doseit differ? | |
| Region |
|
|
| Condition | ||
| Condition | Finished | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | comparison of preoperative versus postoperative administration of misoprostol rectally in minimizing intraoperative blood loss and prevention of postpartum hemorrhage |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | amount of blood loss intraoperative and postoperative |
| Key secondary outcomes | Drop in hematocrite level 24 hours after cesarean section and any drug related complications |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Preoperative misoprostol received 400 microgram misoprostol after anesthesia at time catheter fixation | |
| Interventions/Control_2 | postoperative misoprostol received 400microgram misoprostol after the end of cesarean section | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | full term pregnancy 37-40 weeks
planned elective cesarean delivery regional spinal anesthesia |
|||
| Key exclusion criteria | conditions prolonging surgical time or causing atony as: general anesthesia , antepartum hemorrahge
coagulation disorders Previous 2 or more cesarean sections previous rupture uterus muliple pregnancies, polyhydramios or macrosomia |
|||
| Target sample size | 180 | |||
| Research contact person | |
| Name of lead principal investigator | Ayman Shehata Dawood |
| Organization | Tanta University |
| Division name | Ayman Shehata Dawood |
| Address | Tanta University, Faculty of Medicine, Department of Obstetrics and Gynecology, Tanta, Al Gharbia, Egypt |
| TEL | 00201020972067 |
| ayman.dawood@med.tanta.edu.eg | |
| Public contact | |
| Name of contact person | Ayman Shehata Dawood |
| Organization | Tanta University |
| Division name | Ayman Shehata Dawood |
| Address | Tanta University, Faculty of Medicine, Department of Obstetrics and Gynecology, Tanta, Al Gharbia, E |
| TEL | 00201020972067 |
| Homepage URL | |
| ayman.dawood@med.tanta.edu.eg | |
| Sponsor | |
| Institute | Tanta University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tanta University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | Hesham M Borg |
| Org. issuing International ID_1 | Tanta University |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029196 |